Author Topic: (Abst.) Effect of Ocrevus on vaccine responses in patients w/MS  (Read 64 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9842
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Effect of Ocrevus on vaccine responses in patients w/MS
« on: September 25, 2020, 11:29:02 am »
From PubMed (August 1, 2020), "Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study":


https://pubmed.ncbi.nlm.nih.gov/32727835/
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
140 Views
Last post May 01, 2018, 07:14:22 am
by agate
0 Replies
63 Views
Last post August 07, 2020, 02:51:51 pm
by agate
1 Replies
66 Views
Last post August 26, 2021, 06:56:59 pm
by agate
0 Replies
52 Views
Last post September 17, 2021, 08:18:27 pm
by agate
0 Replies
24 Views
Last post May 24, 2022, 09:39:45 pm
by agate